JPRN-UMIN000005309已完成未知
A double-blind, randomized controlled pilot study of olive leaf extracts(OLE) for the prevention of periodontal diseases. - Pilot study of OLE for the prevention of periodontal diseases.
Department of Preventive Dentistry, Osaka University Graduate School of Dentistry0 个研究点目标入组 45 人开始时间: 2011年3月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 49years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Those who took periodontal surgical therapy within 6 months Those who are pregnant or lactating Those who have a history of systematic diseases Those who took antibiotics within 3 months Those who took anti-inflammatory drugs within 2 weeks Those who have unrestored caries Those who smoke within 6 months Those who participate in other clinical trial Those who are judged not eligible for the study subjects by their investigators
研究者
相似试验
尚未招募
3 期
Do bisphosphonate tablets improve bone health in patients on dialysisEnd Stage Kidney Diseasefracture riskRenal and Urogenital - Kidney diseaseMusculoskeletal - OsteoporosisACTRN12620000321943Westmead Hospital Research and Education Network114
招募中
不适用
The distribution and duration of the sensory block after a standard and refined ultrasound guided transversus abdominis plane (TAP) block.ACTRN12610000094077Dr Phillip Cowlishaw20
招募中
Unknown
A double-blind, randomized controlled trial study on the preventive effect of cetylpyridinium chloride containing mouthwash on gingivitis during orthodontic treatmentgingivitisJPRN-UMIN000051198Ministry of Education, Culture, Sports, Science and Technology60
进行中（未招募）
不适用
A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) - NAThis study aims to assess the safety of PSD506 in men with benign prostatic enlargement (BPE) / benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) and an IPSS of 8-19, in line with Americian Association recommendations.MedDRA version: 8.1Level: LLTClassification code 10055026Term: Prostatic obstructionEUCTR2006-002055-32-DEPlethora Solutions Limited80
进行中（未招募）
1 期
A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naïve or previously treated (washed out) patients with benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS) - PSD506-OAB-004benign prostatic obstruction (BPO) and lower urinary tract symptoms (LUTS)MedDRA version: 8.1 Level: LLT Classification code 10055026 Term: Prostatic obstructionEUCTR2006-002055-32-IEPlethora Solutions Limited80